DDrare: Database of Drug Development for Rare Diseases

Turmeric (DrugBank: Turmeric)

5 diseases

ID	Disease name (Link within this page)	Number of trials
96	Crohn disease	0
140	Dorabe syndrome	1
144	Lennox-Gastaut syndrome	1
158	Tuberous sclerosis	1
299	Cystic fibrosis	1

96. Crohn disease [ 2,209 clinical trials, 1,276 drugs, (DrugBank: 240 drugs), 166 drug target genes, 210 drug target pathways]

Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.

0 / 2,209 trial found

140. Dorabe syndrome [ 83 clinical trials, 54 drugs, (DrugBank: 13 drugs), 48 drug target genes, 62 drug target pathways]

Searched query = "Dorabe syndrome", "Dravet syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 83 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03254680 (ClinicalTrials.gov)	March 2018	15/8/2017	Turmeric as Treatment in Epilepsy	Turmeric as Treatment in Epilepsy	Epilepsy;Dravet Syndrome;Lennox-Gastaut Syndrome;Tuberous Sclerosis;Focal Seizures	Dietary Supplement: Turmeric	NYU Langone Health	NULL	Withdrawn	1 Year	70 Years	All	0	N/A	United States

144. Lennox-Gastaut syndrome [ 80 clinical trials, 63 drugs, (DrugBank: 11 drugs), 49 drug target genes, 59 drug target pathways]

Searched query = "Lennox-Gastaut syndrome"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 80 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03254680 (ClinicalTrials.gov)	March 2018	15/8/2017	Turmeric as Treatment in Epilepsy	Turmeric as Treatment in Epilepsy	Epilepsy;Dravet Syndrome;Lennox-Gastaut Syndrome;Tuberous Sclerosis;Focal Seizures	Dietary Supplement: Turmeric	NYU Langone Health	NULL	Withdrawn	1 Year	70 Years	All	0	N/A	United States

158. Tuberous sclerosis [ 100 clinical trials, 62 drugs, (DrugBank: 16 drugs), 35 drug target genes, 115 drug target pathways]

Searched query = "Tuberous sclerosis", "Tuberous sclerosis complex"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 100 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT03254680 (ClinicalTrials.gov)	March 2018	15/8/2017	Turmeric as Treatment in Epilepsy	Turmeric as Treatment in Epilepsy	Epilepsy;Dravet Syndrome;Lennox-Gastaut Syndrome;Tuberous Sclerosis;Focal Seizures	Dietary Supplement: Turmeric	NYU Langone Health	NULL	Withdrawn	1 Year	70 Years	All	0	N/A	United States

299. Cystic fibrosis [ 1,592 clinical trials, 1,539 drugs, (DrugBank: 255 drugs), 81 drug target genes, 162 drug target pathways]

Searched query = "Cystic fibrosis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

1 / 1,592 trial found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00219882 (ClinicalTrials.gov)	April 2005	16/9/2005	Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis	A Phase I Safety and Dose Finding Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis Who Are Homozygous for Delta F508 Cystic Fibrosis Transmembrane Conductance Regulator (?F508 CFTR) Mutation	Cystic Fibrosis	Drug: standardized turmeric root extract	Ramsey, Bonnie, MD	Seer Pharmaceuticals;CF Therapeutics Development Network Coordinating Center;Cystic Fibrosis Foundation Therapeutics	Completed	18 Years	40 Years	Both	11	Phase 1	United States